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Ventriculoperitoneal shunt infections in children
A 6-year study
M. F. COTTON, B. HARTZENBERG, P. R. DONALD, P. J. BURGER
Summary
In a study of ventriculoperitoneal shunt infections conducted
retrospectively between 1983 and 1987 and prospectively in
1988 39 infections from 372 shunt procedures (incidence
10,5%) were identified. The most common organism isolated
was Staphylococcus aureus (18; 47%) followed by S. epider-
midis (10; 26%). Forty-two per cent of staphylococci were
methicillin-resistant. Gram-negative infections were associated
with myelomeningoceles and Gram-positive infections with
other forms of hydrocephalus (P = 0,048). Lymphocyte pre-
dominance was found more frequently than polymorpho-
nuclear predominance in cerebrospinal fluid.
S Atr Med J 1991; 79: 139-142.
Ventriculoperitoneal (VP) shunts have been the preferred
form of treatment for hydrocephalus since the late 1960s. 1
Shunt infections are an imponant cause of morbidity and
monality in these patients. 1•2 Although a number of surveys of
shunt infections in children have been published from deve-
loped countries,3,6 there is little information available from
developing countries. We are unaware of previous studies
from the African continent.
The purpose of our study was to document the incidence,
aetiology, clinical presentation, cerebrospinal fluid (CSF) fmd-
ings, modes of treatment and outcome of shunt infections at
Tygerberg Hospital, a 2000-bed referral hospital in the south-
western Cape Province.
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Subjects and methods
Patients < 13 years of age with shunt infections were identified
from a register of abnormal CSF fmdings maintained jointly
by the Depanmems of Paediatrics and Child Health and
Medical Microbiology and from a review of all VP shunt
procedures performed by the Depanment of Neurosurgery.
Information on shunt infections was collected retrospectively
from 1983 to. 1987 and prospectively in 1988. From 1984 all
patients undergoing a shunt procedure were given prophylactic
cefamandole.
The following criteria were used to diagnose shunt infections:
(I) microbiological - positive bacterial culture from either
CSF or the wound site; and (il) clinical - signs of inflamma-
tion over the reservoir or shunt tract.
A relapse was regarded as the reappearance of an organism
of the same genus and species within 3 months of cessation of
treatment.
The following information was extracted from the bed-
letters of patients identified as having shunt infections: age;
sex; primary diagnosis; preceding operative procedure (primary
insertion or revision of an existing shunt); time interval between_
operation and diagnosis of infection; CSF fmdings; and site of
positive culture and outcome.
Patients with an axillary temperature ~ 38°C at the time of
diagnosis of shunt infection were regarded as being febrile.
The presence of shunt malfunction, meningism and abdominal
signs (distension, tenderness and peritonitis) was also noted.
All patients received antimicrobial therapy. Treatment was
divided into the following: group 1 - medical treatment only;
group 2 - removal of shunt with intermittent ventricular
drainage and later replacement; group 3 - revision of the
existing shunt; and group 4 - primary external ventricular
drainage with later shunt replacement,
Bacteria were identified by standard laboratory techniques
and antibiotic-sensitivity patterns evaluated by the disc method
of Stokes.7 Anaerobic cultures were done routinely for pus
swabs but not for CSF specimens.
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Results
• 1 patient developed 2 episodes of shunt infection.
t 1 patient developed 3 and another 2 episodes of shunt infection.
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Fig. 1. Cerebrospinal fluid findings (P = polymorphonuclear cell
predominance (> 50% cell count); L = Iymphocyte predominance;
Tr = trace; -- = normal value; -------- = median value).
In I patient the site of isolation was not specified. No
organisms were isolated in 3 patients with shunt infections, all
of whom had tract inflammation. The organisms isolated and
their antibiotic sensitivity profJ.les are shown in Table 11. The
most common organisms isolated were S. aureus in 18 cases
(47%) and S. epidermidis in 10 (26%). Twelve (42%) of staphy-
lococcal isolates were methicillin-resistant. In two episodes of
shunt infection> I organism was isolated from pus swabs. In
one a fi-haemolytic Streptococcus, a clostridial species and S.
aureus were isolated and in the other a Proteus· species and
Streptococcus faecalis. Seven patients had Gram-negative infec-
tions and all but I were sensitive to gentamicin. Four of 7
Gram-negative infections occurred in patients with myelo-
meningocele, I of whom, however, had a mixed Gram-positive
and Gram-negative infection and was excluded from sub-
sequent analysis. The relationship between Gram-negative
infections and myelomeningocele was significant (P = 0,048;
2-tailed Fisher's exact test).
All patients received antimicrobial therapy. The agents most
commonly used for methicillin-sensitive staphylococci were
cloxacillin, sulphadiazine and co-trimoxazole and for methi-
cillin-resistant organisms vancomycin, fusidic acid and rifampi-
cin. Antimicrobial agents were given intrathecally through the
shunt reservoir or through an Omaya reservoir in 5 patients.
(vancomycin in 3, gentamicin in I and amikacin in I).
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TABLE I. PRIMARY DIAGNOSIS OF PATIENTS WITH
VENTRICULOPERITONEAL SHUNT INFECTIONS
No. of
patientsDiagnosis
Myelomeningocele·
Tuberculous meningitis
Other bacterial meningitis
Congenital hydrocephalust
Post intraventricular haemorrhage
Over the 6-year period 372 shunt procedures were performed.
Thirty-nine episodes of shunt infection occurred in 35 patients.
Shunt infection occurred after 25 of 238 primary shunts
(10,4%) and after 14 of 134 revisions of existing shunts (10,5%).
The case fatality rate was 31,4% (N = 11). The median age for
patients with shunt infection was 10 months and mean age
24,2 ± 28,6 months. The primary diagnoses are shown in
Table I. The male:female ratio was 0,95.
The median time interval between shunt procedure and
diagnosis of shunt infection was 24 days. Twenty-seven
occurred within 30 days (69%) and 31 within 60 days (79%) of
the shunt procedure. Three patients had particularly long time
intervals between shunt insertion and onset of shunt infection.
One patient, with a primary diagnosis of tuberculous menin-
gitis, developed shunt infection due to Staphylococcus aureus
103 months after shunt insertion. A contributory factor may
have been meningococcal septicaemia with extensive skin
infarction 3 weeks before diagnosis of shunt infection. The
second, a patient with a myelomeningocele, developed an
Escherichia coli shunt infection 96 months after insertion of the
shunt. She had a urinary tract infection due to a Klebsiella
species 4 months before shunt infection. The third patient
with a primary diagnosis of post-bacterial meningitis developed
an E. coli shunt infection 56 months after insertion of the
shunt. There were no obvious precipitating factors.
The clinical features of shunt infection were as follows.
Fever occurred in 24 patients (61%), tract inflammation in 23
(58%), shunt malfunction in 17 (44%) and meningism in 9
(23%). Abdominal signs were noted in 3 patients (8%), of
whom 1 had distension, I tenderness and 1 peritonitis.
. CSF was evaluated in 30 cases. Our fmdings are shown in
Fig. 1. Four specimens had'::;; 5 white cells X 10611. Organisms·
were shown by Gram stain in 13 cases (45%) and culture in 29
(97%). Organisms were isolated from pus swabs in an additional
6 shunt infections. Of interest is that lymphocyte predominance
was noted in 12 cases (40%) and was more common than
polymorphonuclear cell predominance, which occurred in 7
(23%). Four of 8 patients with aprimary diagnosis of tuber-
culous meningitis had lymphocyte predominance at diagnosis
of shunt infection. Of these, only 1 had active tuberculosis at
the time, having developed shunt infection 13 days after the
start of antituberculosis therapy. Two of the remaining 3
patients developed shunt infections 2 years after having pre-
sented with tuberculous meningitis and 1 after 2 months. A
CSF specimen from the laner patient taken I month before
shunt infection showed 5 lymphocytes X 106/1 and no poly-
morphonuclear cells. At diagnosis· of shunt infection 85 lympho-
cytes and 45 polymorphonuclear cells X 106/1 were docu-
mented.
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TABLE 11. CAUSATIVE ORGANISMS AND THEIR ANTIBIOTIC SENSITIVITY PATTERNS
Gram-positive bacteria
Total Penicillin Methicillin "Co-trimoxazole Fusidic acid Vancomycin
S. aureus
S. epidermidis
Streptococcus sp.
18
10
3 3
10
6
10
1
1
18
10
18
10
Gram-negative bacteria
Gentamicin Co-trimoxazole Cefotaxime
E. coli
Acinetobacter sp.
Pseudomonas sp.
Proteus sp.
Total
3
2
1
1
3
o
1
1
1
o
o
o
2"
1
1
1
Imipenem
" Not tesled in 1 patient.
2 patients had polymicrobial infections (diagnosed from pus swabs).
TABLE Ill. SURGICAL MANAGEMENT AND OUTCOME
Successful
No. of treatment Relapse
Group patients No. % No. %
1 8 3 37,5 3 37,5
2" 22 16 72,7 1 4,5
3 6 2 33,3 0
4 3 2 66,7 1 33,3
Deaths
No. %
2 25,0
5t 22,7
4 66,7
o
• In 3 cases, shunts were not replaced as patients were found 10 be shunt-independent
t Four of 5 deaths occurred before shunt replacement
The results of the various forms of surgical treatment are
shown in Table Ill. The most common procedure undertaken
was shunt removal and later replacement, which was associated
with the highest rate of cure (72,7%) and second lowest
mortality rate (25%). Four of 5 deaths occurred before the
insertion of a new shunt. Also of note is that 4 of 6 patients
who had revisions of their shunts during medical therapy died.
There were no deaths in the small group treated with primary
external ventricular drainage. There were 5 relapses, 4 due to
S. aureus and 1 due to S. epidermidis. Relapses occurred most
commonly where medical treatment alone was anempted.
Discussion
The r70rted incidence of shunt infection ranges from 2% to
30%.1- At present an infection rate > 5 - 7% is considered
=-acceptable in North America. 1 Our infection rate of 10,5%
cOmpares favourably with reported series, but is still too high.
There are no previous studies of VP shunt infection from
Africa, although sepsis has been reported in patients with
veiltriculo-atrial shunts in Soweto, Johannesburg, and in the
S~dan. The incidences of bacteraemia were 7,1% and 2%
re~pectively.8,9 Both studies also made note of a high incidence
of hydrocephalus in the populations studied. The lack of
difference between infection rate for new shunts and revisions
h~ previously been noted.5,6
'The time of diagnosis in relationship to the surgical proce-
dUre is also similar to that of previous studies.J-6 The fact that
3 I'atients developed shunt infections between 56 months and
10:3 months after the shunt procedure suggests that as long as
the: VP shunt, a foreign body, is left in siru, it is at risk for
be(:oming infected. It has been previously noted that while
Gram-positive infections usually occur within 3 months of the
shunt procedure, Gram-negative infections can occur at any
time. I, In contrast, the longest time interval in our series was,
however, for an S. aureus shunt infection.
A CSF finding of interest in our study was that lymphocyte
predominance was found in 40% of cases. Odio er al. 4 found
that in a review of 139 CSF specimens from patients with
shunt malfunction only or in CSF uninfected at the time of
shunt placement there was a tendency to lymphocyre predomi-
nance. In contrast, in the presence of shunt infection, a
predominance of segmented cells was noted. Frame and
McLaurin 10 noted a mononuclear predominance in 1 of7 CSF
specimens associated with shunt infection. The reason for the
lymphocyre predominance in our patients could be that they
presented at a later stage than patients in other series. The
CSF protein, glucose and white-cell estimations are similar to
those reported by Odio er al. 4 and, in general, indicate a mild
inflammatory response.
As in previous studies, we found that staphylococcal species
. were responsible for the majority of shunt infections. In
contrast to other studies,z'6 however, we found that S. aureus
was responsible more often than S. epidermidis. This could
reflect a higher skin carriage rate in children referred to our
hospital. The finding that 42% of staphylococci were methi-
cillin-resistant reflects the tendency for methicillin-resistance
to be more common in hospital environments. Many of our
patients were hospitalised pre-operatively for periods of up to
2 months, thus providing ample opportunity for colonisation
by methicillin-resistant S. aureus. A survey of S. aureus infec-
tions at Tygerberg Hospital in 1985 showed that 48% were
methicillin-resistant.!l We were able to show a relationship
between myelomeningocele and Gram-negative infections that
was significant. Previous studies have shown conflicting results,
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with a lack of association shown by most authors3•6 and a
positive correlation by others. 12
Our management of shunt infection, consisting mainly of
shunt removal, appropriate antimicrobial therapy and later
replacement, is similar to that advocated by some authors. I- 4
We have lanerly been using external VP drainage more
frequently, since this has the advantage of easy access for
administration of antibiotics and for sampling of CSF for
culrure and determination of drug levels. Also, by allowing
continuing CSF drainage, an acute increase in intracranial
pressure is prevented. This mechanism may have been partly
responsible for 4 of the 5 deaths that occurred in group 2
(initial shunt removal and later replacement).
A problem with intravenous administration of some antibio-
tics is unpredictable poor crossing of the blood-brain barrier
by agents such as vancomycin and the aminoglycosides. Also,
long-term intravenous cannulation, besides being technically
difficult and painful, places the patient at risk for compli-
cations, such as suppurative thrombophlebitis. 13 A combination
of oral rifampicin and co-trimoxazole with intrashunt van-
comycin has been used successfully in a series of 11 children
with shunt infection due to susceptible staphylococcal species. 10
There is no unanimity regardinf the role of prophylactic
antibiotics for VP shunt surgery. 1. Nevertheless, the use of
cefamandole at our hospital is clearly inappropriate, since it is
not effective against methicillin-resistant staphylococci. 14
The case fatality rate in our srudy was also similar to that
reponed elsewhere. 3,4 Schoenbaum er al. 3 found a case fatality
rate of 40% in patients with shunt infection and 17% in
patients with uninfected VP shunts. We did not determine the
case fatality rate in this group, mainly because of poor follow-
up records.
Conclusion
We have documented the incidence of VP shunt infection in
children at Tygerberg Hospital. The most common organism
is S. aureus in contrast to other reponed srudies where S.
epidermidis was most common. Almost 50% of staphylococci
were methicillin-resistant. These fmdings have bearing on
appropriate antibiotic therapy. for shunt infections, which
should include cover for methicillin-resistant organisms until
sensitivity panerns are available. In patients with myelo-
meningocele, Gram-negative cover should also be considered
until culture results are available.
There is need for further srudy of both the prevention and
optimal therapy of VP shunt infections.
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